NCT02904330View on ClinicalTrials.gov

K1-70 - A Study in Subjects With Graves' Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
Graves' Disease
Interventions
DRUG

K1-70 intramuscular or K1-70 intravenous

Each subject will receive one dose of K1-70 by IM injection or one dose of K1-70 by IV infusion on the morning of Day 1.

Trial Locations (2)

L7 8XP

Royal Liverpool University Hospital Clinical Research Unit, Liverpool

M23 9QZ

Medicines Evaluation Unit, Manchester

All Listed Sponsors
lead

AV7 Limited

INDUSTRY

NCT02904330 - K1-70 - A Study in Subjects With Graves' Disease | Biotech Hunter | Biotech Hunter